Deep Genomics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 106
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $180M
Latest Deal Amount
  • Investors
  • 18

Deep Genomics General Information

Description

Operator of an AI-Powered genetic medicine discovery platform designed to interpret genetic variation. The company's AI platform uses throughput assays and advanced robotics systems to generate billions of data points and builds dozens of engineered and validated machine learning systems that support drug development, enabling researchers to classify, prioritize, interpret and link genetic variants, whether natural or therapeutic.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Biotechnology
Primary Office
  • MaRS Centre, 661 University Avenue
  • Suite 480
  • Toronto, Ontario M5G 1M1
  • Canada
+1 (647) 000-0000

Deep Genomics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Deep Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 28-Jul-2021 $180M 00000 Completed Startup
4. Later Stage VC (Series B) 07-Jan-2020 0000 0000 Completed Startup
3. Early Stage VC (Series A) 14-Aug-2017 0000 0000 Completed Startup
2. Seed Round 18-Nov-2015 $8M $8M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Deep Genomics’s complete valuation and funding history, request access »

Deep Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an AI-Powered genetic medicine discovery platform designed to interpret genetic variation. The company's AI
Discovery Tools (Healthcare)
Toronto, Canada
106 As of 2022
00000
00000000000 00000

00000000

rit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
000000000 00000 (0000000000)
Toronto, Canada
00 As of 0000
00.000
000000000 00.000

00000

ng elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
00000 0000000000 0000000000 0000000
Paris, France
000 As of 0000
00000
0.000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Deep Genomics Competitors (44)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Phenomic AI Venture Capital-Backed Toronto, Canada 00 00.000 000000000 00.000
00000 Venture Capital-Backed Paris, France 000 00000 00000000000 00000
000000 0000000 Venture Capital-Backed San Diego, CA 00 00000 000000 - 000 00000
000000000 00000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
000000 00000000 Formerly VC-backed Saint Sulpice, Switzerland 000 00000 000000000 00000
You’re viewing 5 of 44 competitors. Get the full list »

Deep Genomics Patents

Deep Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210383890-A1 Systems and methods for classifying, prioritizing and interpreting genetic variants and therapies using a deep neural network Pending 07-Jul-2021 000000000
CA-3128577-A1 Ligand clusters and methods of their use and preparation Pending 28-Feb-2019 0000000000
CA-3107890-A1 Therapeutic splice-switching oligonucleotides Pending 21-Aug-2018 0000000000
US-20200165611-A1 Therapeutic splice-switching oligonucleotides Pending 21-Aug-2018 0000000000 0
EP-3840758-A1 Therapeutic splice-switching oligonucleotides Pending 21-Aug-2018 C12N15/111
To view Deep Genomics’s complete patent history, request access »

Deep Genomics Executive Team (8)

Name Title Board Seat Contact Info
Brendan Frey Ph.D Co-Founder, Chief Executive Officer & Board Member
Amanda Kay Chief Business Officer
Matt Cahill Ph.D Vice President of Finance & Business Operations, Chief of Staff & Board Member
Peter Hutt Advisor
Ferdinand Massari MD Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Deep Genomics Board Members (9)

Name Representing Role Since
Adam D'Augelli True Ventures Board Member 000 0000
Alexander Morgan Ph.D Khosla Ventures Board Member 000 0000
Brendan Frey Ph.D Deep Genomics Co-Founder, Chief Executive Officer & Board Member 000 0000
Dion Madsen Self Board Observer 000 0000
Elena Viboch SoftBank Investment Advisers Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Deep Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Deep Genomics Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Canada Pension Plan Investment Board Limited Partner Minority 000 0000 000000 0
Fidelity Management & Research PE/Buyout Minority 000 0000 000000 0
SoftBank Investment Advisers Growth/Expansion Minority 000 0000 000000 0
Tekla Capital Management Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »